Cargando…

Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?

INTRODUCTION: Tumors of the ovary and appendix have been well documented in the setting of pseudomyxoma peritonei (PMP) with constant debate over tumor origin. Generally, these tumors are found to have a single primary origin, most commonly the appendix, with metastatic spread to the ovaries. CARE P...

Descripción completa

Detalles Bibliográficos
Autores principales: Yehya, Misbah, Denson, Matthew, Moszczynski, Zbigniew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948249/
https://www.ncbi.nlm.nih.gov/pubmed/31901742
http://dx.doi.org/10.1016/j.ijscr.2019.12.027
_version_ 1783485706468851712
author Yehya, Misbah
Denson, Matthew
Moszczynski, Zbigniew
author_facet Yehya, Misbah
Denson, Matthew
Moszczynski, Zbigniew
author_sort Yehya, Misbah
collection PubMed
description INTRODUCTION: Tumors of the ovary and appendix have been well documented in the setting of pseudomyxoma peritonei (PMP) with constant debate over tumor origin. Generally, these tumors are found to have a single primary origin, most commonly the appendix, with metastatic spread to the ovaries. CARE PRESENTATION: Here we present a 61-year-old female who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO) for a primary mucinous ovarian carcinoma. She presented to our institution one year later with abdominal pain and a palpable right lower quadrant mass, which on histopathologic exam was found to be a primary low grade mucinous appendiceal neoplasm (LAMN), alluding to the potential of two separate primary disease processes. DISCUSSION/CONCLUSION: With two primary, non-synchronous lesions, a thorough literature review suggests that during the patient's initial TAH-BSO, she could have additionally undergone an appendectomy. In doing so, this would provide accurate, complete staging and determine if the two neoplasms were truly primary in origin or metastatic. In addition, new genetic markers are being discovered, such as the Special AT-rich sequence-binding protein 2 (SATB2) marker, which has been found to be positive in those with a LAMN and negative in those with a primary mucinous ovarian carcinoma. By acquiring appropriate and complete staging we can better diagnose and treat these neoplasms.
format Online
Article
Text
id pubmed-6948249
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-69482492020-01-09 Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors? Yehya, Misbah Denson, Matthew Moszczynski, Zbigniew Int J Surg Case Rep Article INTRODUCTION: Tumors of the ovary and appendix have been well documented in the setting of pseudomyxoma peritonei (PMP) with constant debate over tumor origin. Generally, these tumors are found to have a single primary origin, most commonly the appendix, with metastatic spread to the ovaries. CARE PRESENTATION: Here we present a 61-year-old female who underwent total abdominal hysterectomy and bilateral salpingo-oophorectomy (TAH-BSO) for a primary mucinous ovarian carcinoma. She presented to our institution one year later with abdominal pain and a palpable right lower quadrant mass, which on histopathologic exam was found to be a primary low grade mucinous appendiceal neoplasm (LAMN), alluding to the potential of two separate primary disease processes. DISCUSSION/CONCLUSION: With two primary, non-synchronous lesions, a thorough literature review suggests that during the patient's initial TAH-BSO, she could have additionally undergone an appendectomy. In doing so, this would provide accurate, complete staging and determine if the two neoplasms were truly primary in origin or metastatic. In addition, new genetic markers are being discovered, such as the Special AT-rich sequence-binding protein 2 (SATB2) marker, which has been found to be positive in those with a LAMN and negative in those with a primary mucinous ovarian carcinoma. By acquiring appropriate and complete staging we can better diagnose and treat these neoplasms. Elsevier 2019-12-26 /pmc/articles/PMC6948249/ /pubmed/31901742 http://dx.doi.org/10.1016/j.ijscr.2019.12.027 Text en © 2019 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Yehya, Misbah
Denson, Matthew
Moszczynski, Zbigniew
Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
title Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
title_full Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
title_fullStr Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
title_full_unstemmed Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
title_short Multi-origin mucinous neoplasm: Should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
title_sort multi-origin mucinous neoplasm: should we prophylactically remove the appendix in the setting of mucinous ovarian tumors?
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6948249/
https://www.ncbi.nlm.nih.gov/pubmed/31901742
http://dx.doi.org/10.1016/j.ijscr.2019.12.027
work_keys_str_mv AT yehyamisbah multioriginmucinousneoplasmshouldweprophylacticallyremovetheappendixinthesettingofmucinousovariantumors
AT densonmatthew multioriginmucinousneoplasmshouldweprophylacticallyremovetheappendixinthesettingofmucinousovariantumors
AT moszczynskizbigniew multioriginmucinousneoplasmshouldweprophylacticallyremovetheappendixinthesettingofmucinousovariantumors